Publicacións nas que colabora con ANXO VIDAL FIGUEROA (26)

2023

  1. Matrices Activadas con ARNm como Sistema para la Regeneración de Cartílago Articular

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer

    Nature Communications, Vol. 13, Núm. 1

  2. Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer (Nature Communications, (2022), 13, 1, (4829), 10.1038/s41467-022-31859-3)

    Nature Communications

2021

  1. Delivery of transcription factors as modulators of cell differentiation

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 426-444

  2. O-GlcNAcylated p53 in the liver modulates hepatic glucose production

    Nature Communications, Vol. 12, Núm. 1

  3. Small extracellular vesicle-mediated targeting of hypothalamic AMPKα1 corrects obesity through BAT activation

    Nature Metabolism, Vol. 3, Núm. 10, pp. 1415-1431

2020

  1. Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds (Nature Communications, (2019), 10, 1, (4731), 10.1038/s41467-019-12888-x)

    Nature Communications

  2. mRNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering

    Biomaterials, Vol. 247

2019

  1. A multifunctional drug nanocarrier for efficient anticancer therapy

    Journal of Controlled Release, Vol. 294, pp. 154-164

  2. p107 Deficiency Increases Energy Expenditure by Inducing Brown-Fat Thermogenesis and Browning of White Adipose Tissue

    Molecular Nutrition and Food Research, Vol. 63, Núm. 2

2017

  1. Corrigendum: Hepatic p63 regulates steatosis via IKKβ/ER stress

    Nature communications

  2. Hepatic p63 regulates steatosis via IKKβ/ER stress

    Nature Communications, Vol. 8

  3. New scaffolds encapsulating TGF-β3/BMP-7 combinations driving strong chondrogenic differentiation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 69-78

2016

  1. Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer

    Journal of Controlled Release, Vol. 238, pp. 263-271

  2. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size

    International Journal of Pharmaceutics, Vol. 509, Núm. 1-2, pp. 107-117

  3. Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node

    Journal of Nanobiotechnology, Vol. 14, Núm. 1

2015

  1. HOW REGENERATIVE MEDICINE CAN BENEFIT FROM NUCLEIC ACIDS DELIVERY NANOCARRIERS?

    POLYMERS IN REGENERATIVE MEDICINE: BIOMEDICAL APPLICATIONS FROM NANO- TO MACRO-STRUCTURES (BLACKWELL SCIENCE PUBL), pp. 285-336

2014

  1. How Regenerative Medicine Can Benefit from Nucleic Acids Delivery Nanocarriers?

    Polymers in Regenerative Medicine: Biomedical Applications from Nano- to Macro-Structures (wiley), pp. 285-336

2013

  1. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 330-337

  2. Chitosan-based nanomaterials for drug delivery and antibiotic-free bacterial control

    Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013